QIU, Yao-ling,WANG, Ce,PENG, Xiaowen,YING, Lu,OR, Yat Sun
申请号：
AU2013204195
公开号：
AU2013204195B2
申请日:
2013.04.12
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2013204195B220160922.pdf#####H: ftintcnvoven NRPortbl DCC FMT5O70377_3.DOC-12/04/2013 ABSTRACT The present invention discloses compounds or pharmaceutically acceptable salts, esters, or prodrugs thereof, which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
